Findings

What do systematic reviews say?

25 questions · 25 findings · 12 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 5 · 20%GRADE not reported 7 · 28%Very low 2 · 8%Low 9 · 36%Moderate 2 · 8%High 0 · 0%

Chinese herbal medicines vs Western medicine

Quality of life · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese medicine vs placebo or usual care

Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Chinese herbal medicines vs placebo

Quality of life · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese herbal medicines vs no intervention

Quality of life · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Chinese herbal medicines plus western medicine vs Western medicine

Quality of life (Bushenhuoxue therapy plus calcium carbonate tablets and alfacalcidol versus calcium carbonate tablets and alfacalcidol) · patients with osteoporosis

1 finding from 1 review

Chinese herbal medicines for treating osteoporosis 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Chinese herbal medicines vs placebo

Vasomotor symptoms (vasomotor) · women with menopausal symptoms

1 finding from 1 review

Chinese herbal medicine for menopausal symptoms 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 256 participants
Low

Curcuma longa vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 89 participants
Moderate

STW5 (Iberogast) vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 52 participants
Low

Peppermint/caraway oil vs placebo

Quality of life · patients with functional dyspepsia

1 finding from 1 review

Non‐Chinese herbal medicines for functional dyspepsia 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 99 participants
Moderate

Chinese herbal medicines vs CHM

Quality of life · women with recurrent UTI

1 finding from 1 review

Chinese herbal medicine for treating recurrent urinary tract infections in women 2015 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Very low

Intervention not reported

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for benign thyroid nodules in adults 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Health‐related quality of life · participants with hypertriglyceridaemia

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for hypertriglyceridaemia 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xuezhikang vs pravastatin

Health‐related quality of life ‐ not reported · patients with hypercholesterolemia

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for hypercholesterolemia 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Xuezhikang vs simvastatin

Health‐related quality of life ‐ not reported · patients with hypercholesterolemia

The review found no eligible studies for this question.

1 finding from 1 review

Chinese herbal medicines for hypercholesterolemia 2011 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Active cancer therapy combined with TCM vs active cancer therapy

Quality of life ‐ number experiencing improvement · patients with oesophageal cancer

Active cancer therapy combined with TCM may leads to higher quality of life ‐ number experiencing improvement compared with active cancer therapy (low certainty).

1 finding from 1 review

Chinese herbal medicine for oesophageal cancer 2016 · Cochrane Headline outcomes only
RR 2.2 [1.42, 3.39]
5 studies · 233 participants
Low

Active cancer therapy combined with TCM vs active cancer therapy

Quality of life ‐ number experiencing deterioration · patients with oesophageal cancer

Active cancer therapy combined with TCM may leads to lower quality of life ‐ number experiencing deterioration compared with active cancer therapy (low certainty).

1 finding from 1 review

Chinese herbal medicine for oesophageal cancer 2016 · Cochrane Headline outcomes only
RR 0.41 [0.27, 0.62]
6 studies · 287 participants
Low

Rheum officinale vs captopril

Full time working capacity Unclear quality of life scale · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)

Rheum officinale showed no clear difference in full time working capacity Unclear quality of life scale compared with captopril (low certainty).

1 finding from 1 review

Rheum officinale (a traditional Chinese medicine) for chronic kidney disease 2012 · Cochrane Headline outcomes only
RR 1.02 [0.39, 2.71]
1 study · 20 participants
Low

Rheum officinale vs captopril

Part‐time working capacity Unclear quality of life scale · people with chronic kidney disease (predialysis (GFR 15 to 60 mL/min/1.73 m²), HD, PD, transplant recipients)

Rheum officinale showed no clear difference in part‐time working capacity Unclear quality of life scale compared with captopril (low certainty).

1 finding from 1 review

Rheum officinale (a traditional Chinese medicine) for chronic kidney disease 2012 · Cochrane Headline outcomes only
RR 1.64 [0.38, 6.98]
1 study · 20 participants
Low

Shengmai plus usual treatment vs usual treatment alone

Mean change in quality of life Minnesota Living with Heart Failure Questionnaire (MLWHF) score · patients with heart failure

1 finding from 1 review

Shengmai (a traditional Chinese herbal medicine) for heart failure 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Low

Chinese herbal medicines vs HT

Vasomotor symptoms (vasomotor) · women with menopausal symptoms

1 finding from 1 review

Chinese herbal medicine for menopausal symptoms 2016 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 127 participants
Very low